The next frontier in metabolic health: Cagrilintide-GLP1 and the evolving landscape of therapies
Why Hepatic Impairment Matters for Peptide Therapy Liver dysfunction alters drug pharmacokinetics through reduced metabolic capacity, decreased albumin production, portal-systemic shunting, and impaired biliary excretion
Medications: Certain medications, such as proton pump inhibitors (PPIs) and metformin, can interfere with B12 absorption
Recurrent episodes in a separate pre-clinical OM model also demonstrated continuous microevolution of a haemoglobin-binding gene that resulted in a highly invasive NTHi phenotype that persisted for at least one month following clinical resolution of the infection (Harrison et al., 2020)
When supplementation is necessary, rest assured that all GutsyRx products are free from allergens, dyes, preservatives, and irritating FODMAPs, ensuring they support your gut without unwanted side effects